Lung transplantation for severe pulmonary hypertension - Awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling

Transplantation

Volumn 99, Issue 2, 2015, Pages 451-458

  Tudorache, Igor ^a   Sommer, Wiebke ^a   Kühn, Christian ^a   Wiesner, Olaf ^a   Hadem, Johannes ^a   Fühner, Thomas ^a   Ius, Fabio ^a   Avsar, Murat ^a   Schwerk, Nicolaus ^a   Böthig, Dietmar ^a   Gottlieb, Jens ^a,b   Welte, Tobias ^a,b   Bara, Christoph ^a   Haverich, Axel ^a,b   Hoeper, Marius M ^a,b   Warnecke, Gregor ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b German Centre for Lung Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AORTA DISSECTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; EXTUBATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART INDEX; HEART LEFT VENTRICLE MASS; HEART VENTRICLE REMODELING; HEMODYNAMIC MONITORING; HUMAN; LEG ISCHEMIA; LIVER FAILURE; LUNG TRANSPLANTATION; MALE; PATIENT MONITORING; PULMONARY HYPERTENSION; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME; ADVERSE EFFECTS; ARTIFICIAL VENTILATION; CASE CONTROL STUDY; ETIOLOGY; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; HYPERTENSION, PULMONARY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; THERAPY; TIME; WAKEFULNESS; YOUNG ADULT;

ADOLESCENT; ADULT; AIRWAY EXTUBATION; CASE-CONTROL STUDIES; CHILD; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VENTILATOR WEANING; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING; WAKEFULNESS; YOUNG ADULT;

EID: 84923043993     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000348     Document Type: Article

References (30)

1. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 2010;122:156.
2. Hoeper MM, Schwarze M, Ehlerding S, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000;342:1866.
3. McLaughlin VV, Shillington A, Rich S. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 2002;106:1477.
4. Kemp K, Savale L, O'Callaghan DS, et al. Usefulness of first-line combination therapy with epoprostenol and bosentan in pulmonary arterial hypertension: an observational study. J Heart Lung Transplant 2012;31:150.
5. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493.
6. Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report - 2008. J Heart Lung Transplant 2008;27:943.
7. Whyte RI, Robbins RC, Altinger J, et al. Heart-lung transplantation for primary pulmonary hypertension. Ann Thorac Surg 1999;67:937.
8. Topilsky M, Heller I. Prostacyclin in primary pulmonary hypertension: a bridge to heart-lung transplantation. Isr J Med Sci 1993;29:656.
9. Franke U, Wiebe K, Harringer W, et al. Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension. Eur J Cardiothorac Surg 2000;18:447.
10. Diamond JM, Lee JC, Kawut SM, et al. Clinical risk factors for primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med 2013;187:527.
11. Kuntz CL, Hadjiliadis D, Ahya VN, et al. Risk factors for early primary graft dysfunction after lung transplantation: a registry study. Clin Transplant 2009;23:819.
12. Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: recipient-related risk factors and markers. J Heart Lung Transplant 2005;24:1468.
13. Halldorsson AO, Kronon M, Allen BS, et al. Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation. Ann Thorac Surg 1998;66:877.
14. Bittner HB, Binner C, Lehmann S, Kuntze T, Rastan A, Mohr FW. Replacing cardiopulmonary bypass with extracorporeal membrane oxygenation in lung transplantation operations. Eur J Cardiothorac Surg 2007;31:462.
15. Pereszlenyi A, Lang G, Steltzer H, et al. Bilateral lung transplantation with intra- and postoperatively prolonged ECMO support in patients with pulmonary hypertension. Eur J Cardiothorac Surg 2002;21:858.
16. Ius F, Kuehn C, Tudorache I, et al. Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass. J Thorac Cardiovasc Surg 2012; 144:1510.
17. Glassman LR, Keenan RJ, Fabrizio MC, et al. Extracorporeal membrane oxygenation as an adjunct treatment for primary graft failure in adult lung transplant recipients. J Thorac Cardiovasc Surg 1995; 110:723.
18. Meyers BF, Sundt TM 3rd, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg 2000;120:20.
19. Nguyen DQ, Kulick DM, Bolman RM 3rd, Dunitz JM, Hertz MI, Park SJ. Temporary ECMO support following lung and heart-lung transplantation. J Heart Lung Transplant 2000;19:313.
20. Fuehner T, Kuehn C, Hadem J, et al. Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation. Am J Respir Crit Care Med 2012;185:763.
21. Olsson KM, Simon A, Strueber M, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010;10:2173.
22. Christie JD, Edwards LB, Aurora P, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report - 2009. J Heart Lung Transplant 2009;28:1031.
23. Franke UF, Wahlers T, Wittwer T, et al. Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension. Transplant Proc 2002;34:2181.
24. Birsan T, Kranz A, Mares P, et al. Transient left ventricular failure following bilateral lung transplantation for pulmonary hypertension. J Heart Lung Transplant 1999;18:304.
25. Verbelen T, Van Cromphaut S, Rega F, Meyns B. Acute left ventricular failure after bilateral lung transplantation for idiopathic pulmonary arterial hypertension. J Thorac Cardiovasc Surg 2013;145:e7.
26. Okada Y, Hoshikawa Y, Ejima Y, et al. Beta-blocker prevented repeated pulmonary hypertension episodes after bilateral lung transplantation in a patient with primary pulmonary hypertension. J Thorac Cardiovasc Surg 2004;128:793.
27. Dalton HJ. Extracorporeal life support: moving at the speed of light. Respiratory care 2011;56:1445.
28. Hardziyenka M, Campian ME, Reesink HJ, et al. Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass evidence for atrophic remodeling. J Am Coll Cardiol 2011;57:921.
29. Tischler MD, Sutton MS, Bittl JA, Parker JD. Effects of percutaneous mitral valvuloplasty on left ventricular mass and volume. Am J Cardiol 1991;68:940.
30. Rensing BJ, McDougall JC, Breen JF, Vigneswaran WT, McGregor CG, Rumberger JA. Right and left ventricular remodeling after orthotopic single lung transplantation for end-stage emphysema. J Heart Lung Transplant 1997;16:926.